Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
{
"resourceType" : "Group",
"id" : "172480",
"meta" : {
"versionId" : "7",
"lastUpdated" : "2023-12-04T16:22:54.673Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/outcome-definition"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Group</b><a name=\"172480\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Group "172480" Version "7" Updated "2023-12-04 16:22:54+0000" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-outcome-definition.html\">OutcomeDefinition</a></p></div><p><b>Artifact related artifact</b>: </p><p><b>Artifact Title</b>: OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control</p><p><b>Artifact URL</b>: <a href=\"https://fevir.net/resources/Group/172480\">https://fevir.net/resources/Group/172480</a></p><p><b>Artifact Publisher</b>: Computable Publishing LLC</p><p><b>Artifact Copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p><p><b>Artifact Contact</b>: <a href=\"mailto:support@computablepublishing.com\">support@computablepublishing.com</a></p><p><b>Artifact Author</b>: Brian S. Alper: </p><p><b>CombinationMethod</b>: all-of</p><blockquote><p><b>modifierExtension[http://hl7.org/fhir/StructureDefinition/artifact-status]</b></p></blockquote><p><b>identifier</b>: FEvIR Object Identifier:\u00a0172480</p><p><b>type</b>: animal</p><p><b>membership</b>: definitional</p><p><b>name</b>: OutcomeDefinition_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control</p><p><b>description</b>: The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years</p><blockquote><p><b>characteristic</b></p><p><b>CharacteristicDescription</b>: hemoglobin A1c less than 7.0%</p><blockquote><p><b>CharacteristicTiming</b></p><blockquote><p><b>url</b></p><code>contextCode</code></blockquote><p><b>value</b>: Enrollment in clinical trial <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#709491003)</span></p><blockquote><p><b>url</b></p><code>offset</code></blockquote><p><b>value</b>: 5 years<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code a = 'a')</span></p><blockquote><p><b>url</b></p><code>text</code></blockquote><p><b>value</b>: at 5 years</p></blockquote><p><b>code</b>: Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#59261-8)</span></p><p><b>value</b>: <7 %<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code % = '%')</span></p><p><b>exclude</b>: false</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>CharacteristicDescription</b>: low-density lipoprotein cholesterol less than 100 mg/dL</p><blockquote><p><b>CharacteristicTiming</b></p><blockquote><p><b>url</b></p><code>contextCode</code></blockquote><p><b>value</b>: Enrollment in clinical trial <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#709491003)</span></p><blockquote><p><b>url</b></p><code>offset</code></blockquote><p><b>value</b>: 5 years<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code a = 'a')</span></p><blockquote><p><b>url</b></p><code>text</code></blockquote><p><b>value</b>: at 5 years</p></blockquote><p><b>code</b>: Cholesterol in LDL [Mass/volume] in Serum or Plasma <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#2089-1)</span></p><p><b>value</b>: <100 mg/dL<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg/dL = 'mg/dL')</span></p><p><b>exclude</b>: false</p></blockquote><blockquote><p><b>characteristic</b></p><p><b>CharacteristicDescription</b>: systolic blood pressure less than 130 mm Hg</p><blockquote><p><b>CharacteristicTiming</b></p><blockquote><p><b>url</b></p><code>contextCode</code></blockquote><p><b>value</b>: Enrollment in clinical trial <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#709491003)</span></p><blockquote><p><b>url</b></p><code>offset</code></blockquote><p><b>value</b>: 5 years<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code a = 'a')</span></p><blockquote><p><b>url</b></p><code>text</code></blockquote><p><b>value</b>: at 5 years</p></blockquote><p><b>code</b>: Systolic blood pressure <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#8480-6)</span></p><p><b>value</b>: <130 mm Hg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mm[Hg] = 'mm[Hg]')</span></p><p><b>exclude</b>: false</p></blockquote></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact",
"valueRelatedArtifact" : {
"type" : "cite-as",
"citation" : "OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 172480. Revised 2023-11-02. Available at: https://fevir.net/resources/Group/172480. Computable resource at: https://fevir.net/resources/Group/172480."
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-title",
"valueString" : "OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-url",
"valueUri" : "https://fevir.net/resources/Group/172480"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-publisher",
"valueString" : "Computable Publishing LLC"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-copyright",
"valueMarkdown" : "https://creativecommons.org/licenses/by-nc-sa/4.0/"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-contact",
"valueContactDetail" : {
"telecom" : [
{
"system" : "email",
"value" : "support@computablepublishing.com"
}
]
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-author",
"valueContactDetail" : {
"name" : "Brian S. Alper"
}
},
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/combination-method",
"valueCode" : "all-of"
}
],
"modifierExtension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-status",
"valueCode" : "active"
}
],
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net",
"value" : "172480",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"type" : "animal",
"membership" : "definitional",
"name" : "OutcomeDefinition_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control",
"description" : "The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years",
"characteristic" : [
{
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description",
"valueMarkdown" : "hemoglobin A1c less than 7.0%"
},
{
"extension" : [
{
"url" : "contextCode",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "709491003",
"display" : "Enrollment in clinical trial"
}
]
}
},
{
"url" : "offset",
"valueDuration" : {
"value" : 5,
"unit" : "years",
"system" : "http://unitsofmeasure.org",
"code" : "a"
}
},
{
"url" : "text",
"valueString" : "at 5 years"
}
],
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-timing"
}
],
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "59261-8",
"display" : "Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol"
}
]
},
"valueQuantity" : {
"value" : 7,
"comparator" : "<",
"unit" : "%",
"system" : "http://unitsofmeasure.org",
"code" : "%"
},
"exclude" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description",
"valueMarkdown" : "low-density lipoprotein cholesterol less than 100 mg/dL"
},
{
"extension" : [
{
"url" : "contextCode",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "709491003",
"display" : "Enrollment in clinical trial"
}
]
}
},
{
"url" : "offset",
"valueDuration" : {
"value" : 5,
"unit" : "years",
"system" : "http://unitsofmeasure.org",
"code" : "a"
}
},
{
"url" : "text",
"valueString" : "at 5 years"
}
],
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-timing"
}
],
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "2089-1",
"display" : "Cholesterol in LDL [Mass/volume] in Serum or Plasma"
}
]
},
"valueQuantity" : {
"value" : 100,
"comparator" : "<",
"unit" : "mg/dL",
"system" : "http://unitsofmeasure.org",
"code" : "mg/dL"
},
"exclude" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description",
"valueMarkdown" : "systolic blood pressure less than 130 mm Hg"
},
{
"extension" : [
{
"url" : "contextCode",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "709491003",
"display" : "Enrollment in clinical trial"
}
]
}
},
{
"url" : "offset",
"valueDuration" : {
"value" : 5,
"unit" : "years",
"system" : "http://unitsofmeasure.org",
"code" : "a"
}
},
{
"url" : "text",
"valueString" : "at 5 years"
}
],
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-timing"
}
],
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "8480-6",
"display" : "Systolic blood pressure"
}
]
},
"valueQuantity" : {
"value" : 130,
"comparator" : "<",
"unit" : "mm Hg",
"system" : "http://unitsofmeasure.org",
"code" : "mm[Hg]"
},
"exclude" : false
}
]
}
IG © 2022+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot based on FHIR 5.0.0. Generated 2023-12-17
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change